Christian G Meyer

Summary

Affiliation: University of Hamburg
Country: Germany

Publications

  1. ncbi Systemic bacteraemia in children presenting with clinical pneumonia and the impact of non-typhoid salmonella (NTS)
    Norbert G Schwarz
    Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    BMC Infect Dis 10:319. 2010
  2. ncbi MCP1 haplotypes associated with protection from pulmonary tuberculosis
    Christopher D Intemann
    Bernhard Nocht Institute for Tropical Medicine, Dept Molecular Medicine, Hamburg, Germany
    BMC Genet 12:34. 2011
  3. ncbi Genetic diversity of Plasmodium falciparum: asexual stages
    Christian G Meyer
    Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    Trop Med Int Health 7:395-408. 2002
  4. ncbi Novel TMC1 structural and splice variants associated with congenital nonsyndromic deafness in a Sudanese pedigree
    Christian G Meyer
    Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    Hum Mutat 25:100. 2005
  5. ncbi IL10 haplotype associated with tuberculin skin test response but not with pulmonary TB
    Thorsten Thye
    Bernhard Nocht Institute for Tropical Medicine, Department of Molecular Medicine, Hamburg, Germany
    PLoS ONE 4:e5420. 2009
  6. ncbi CTLA4 autoimmunity-associated genotype contributes to severe pulmonary tuberculosis in an African population
    Thorsten Thye
    Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    PLoS ONE 4:e6307. 2009
  7. ncbi Malaria incidence and efficacy of intermittent preventive treatment in infants (IPTi)
    Robin Kobbe
    Infectious Disease Epidemiology Group, Bernhard Nocht Institute for Tropical Medicine, Bernhard Nocht Strasse 74, D 20359 Hamburg, Germany
    Malar J 6:163. 2007
  8. ncbi Seasonal variation and high multiplicity of first Plasmodium falciparum infections in children from a holoendemic area in Ghana, West Africa
    Robin Kobbe
    Infection Epidemiology Group, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    Trop Med Int Health 11:613-9. 2006
  9. ncbi MCP-1 promoter variant -362C associated with protection from pulmonary tuberculosis in Ghana, West Africa
    Thorsten Thye
    Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    Hum Mol Genet 18:381-8. 2009
  10. ncbi Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains
    Christopher D Intemann
    Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    PLoS Pathog 5:e1000577. 2009

Collaborators

Detail Information

Publications32

  1. ncbi Systemic bacteraemia in children presenting with clinical pneumonia and the impact of non-typhoid salmonella (NTS)
    Norbert G Schwarz
    Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    BMC Infect Dis 10:319. 2010
    ..In order to assess the spectrum of bacterial pathogens, blood cultures were performed in children fulfilling the clinical criteria of pneumonia...
  2. ncbi MCP1 haplotypes associated with protection from pulmonary tuberculosis
    Christopher D Intemann
    Bernhard Nocht Institute for Tropical Medicine, Dept Molecular Medicine, Hamburg, Germany
    BMC Genet 12:34. 2011
    ..This inconsistency prompted us to further investigate the MCP1 gene in order to determine causal variants or haplotypes genetically and functionally...
  3. ncbi Genetic diversity of Plasmodium falciparum: asexual stages
    Christian G Meyer
    Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    Trop Med Int Health 7:395-408. 2002
  4. ncbi Novel TMC1 structural and splice variants associated with congenital nonsyndromic deafness in a Sudanese pedigree
    Christian G Meyer
    Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    Hum Mutat 25:100. 2005
    ....
  5. ncbi IL10 haplotype associated with tuberculin skin test response but not with pulmonary TB
    Thorsten Thye
    Bernhard Nocht Institute for Tropical Medicine, Department of Molecular Medicine, Hamburg, Germany
    PLoS ONE 4:e5420. 2009
    ..In these PPD-negative individuals, higher IL-10 production appears to reflect IL-10-dependent suppression of adaptive immune responses and sustained long-term specific anergy...
  6. ncbi CTLA4 autoimmunity-associated genotype contributes to severe pulmonary tuberculosis in an African population
    Thorsten Thye
    Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    PLoS ONE 4:e6307. 2009
    ..002, P(cor) = 0.00045, P = 0.0005, respectively). This finding suggests that an increased T-cell activity associated with the CTLA4 +6230G allele contributes to pathology rather than to protection in pulmonary TB...
  7. ncbi Malaria incidence and efficacy of intermittent preventive treatment in infants (IPTi)
    Robin Kobbe
    Infectious Disease Epidemiology Group, Bernhard Nocht Institute for Tropical Medicine, Bernhard Nocht Strasse 74, D 20359 Hamburg, Germany
    Malar J 6:163. 2007
    ..The aim of this study was to determine how far the protective efficacy of IPTi depends on spatio-temporal variations of the prevailing incidence of malaria...
  8. ncbi Seasonal variation and high multiplicity of first Plasmodium falciparum infections in children from a holoendemic area in Ghana, West Africa
    Robin Kobbe
    Infection Epidemiology Group, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    Trop Med Int Health 11:613-9. 2006
    ..To assess the prevalence and multiplicity of Plasmodium falciparum infections in Ghanaian infants...
  9. ncbi MCP-1 promoter variant -362C associated with protection from pulmonary tuberculosis in Ghana, West Africa
    Thorsten Thye
    Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    Hum Mol Genet 18:381-8. 2009
    ..004). Linkage disequilibrium (LD) and logistic regression analyses indicate that, in Ghanaians, the effect results exclusively from the MCP-1 -362 variant, whereas the effect of -2581 may in part be explained by its LD with -362...
  10. ncbi Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains
    Christopher D Intemann
    Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    PLoS Pathog 5:e1000577. 2009
    ..Finally, they raise the possibility that the increased frequency of the IRGM -261TT genotype may have contributed to the establishment of M. africanum as a pathogen in the West African population...
  11. ncbi Pulmonary tuberculosis: virulence of Mycobacterium africanum and relevance in HIV co-infection
    Christian G Meyer
    Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    Tuberculosis (Edinb) 88:482-9. 2008
    ..africanum subtypes West African 1 and West African 2 were compared. In the population studied, M. africanum closely resembled M. tuberculosis in pathology and cannot be considered an opportunistic pathogen...
  12. ncbi High prevalence of markers for sulfadoxine and pyrimethamine resistance in Plasmodium falciparum in the absence of drug pressure in the Ashanti region of Ghana
    Florian Marks
    Department of Molecular Medicine, Bernhard-Nocht Institute for Tropical Medicine, Bernhard Nocht Str. 74, 20359 Hamburg, Germany
    Antimicrob Agents Chemother 49:1101-5. 2005
    ....
  13. ncbi Parasitological rebound effect and emergence of pyrimethamine resistance in Plasmodium falciparum after single-dose sulfadoxine-pyrimethamine
    Florian Marks
    Infection Epidemiology Group, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    J Infect Dis 192:1962-5. 2005
    ..S-P, in the setting of IPTi, appears to cause a parasitological rebound effect in which there is selection of drug-resistant parasites for a short period after drug clearance...
  14. ncbi A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants
    Robin Kobbe
    Infectious Disease Epidemiology Group, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    Clin Infect Dis 45:16-25. 2007
    ..It is unknown whether an additional treatment in the second year of life prolongs protection...
  15. ncbi Variant G57E of mannose binding lectin associated with protection against tuberculosis caused by Mycobacterium africanum but not by M. tuberculosis
    Thorsten Thye
    Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    PLoS ONE 6:e20908. 2011
    ..We conclude that MBL binding may facilitate the uptake of M. africanum by macrophages, thereby promoting infection and that selection by TB may have favoured the spread of functional MBL deficiencies in regions endemic for M. africanum...
  16. ncbi Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2
    Thorsten Thye
    Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    Nat Genet 42:739-41. 2010
    ..13-1.27). Our study demonstrates that genome-wide association studies can identify new susceptibility loci for infectious diseases, even in African populations, in which levels of linkage disequilibrium are particularly low...
  17. ncbi Genotyping of IRGM tetranucleotide promoter oligorepeats by fluorescence resonance energy transfer
    Christopher D Intemann
    Bernhard Nocht Institute for Tropical Medicine, Department of Molecular Medicine, Hamburg, Germany
    Biotechniques 46:58-60. 2009
    ..The protocol was evaluated and applied to the typing of a tetranucleotide promoter repeat of the human gene encoding the immunity-related GTPase family, M (IRGM) molecule in >2000 individuals from Ghana, West Africa...
  18. ncbi IL3 variant on chromosomal region 5q31-33 and protection from recurrent malaria attacks
    Christian G Meyer
    Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, D 20359 Hamburg, Germany
    Hum Mol Genet 20:1173-81. 2011
    ..67, P = 3.2 × 10(-8)), respectively, against malaria attacks. The association was confirmed in transmission disequilibrium tests (TDT, qTDT). The results could argue for a role of IL3 in the pathophysiology of falciparum malaria...
  19. ncbi FCGR2A functional genetic variant associated with susceptibility to severe malarial anaemia in Ghanaian children
    Kathrin Schuldt
    Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Bernhard Nocht Strasse 74, Hamburg, Germany
    J Med Genet 47:471-5. 2010
    ....
  20. ncbi Genotyping of Plasmodium falciparum pyrimethamine resistance by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry
    Florian Marks
    Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    Antimicrob Agents Chemother 48:466-72. 2004
    ..As demonstrated by the example of PYR resistance, MALDI-TOF MS allows for rapid and automated high-throughput assessment of drug sensitivity in P. falciparum malaria...
  21. ncbi Rare human IFNG variants
    Thorsten Thye
    Bernhard Nocht Institute for Tropical Medicine, Department of Molecular Medicine, Hamburg, Germany
    J Interferon Cytokine Res 30:219-22. 2010
    ..All variants occurred heterozygously only and were confirmed either by their detection in other individuals and/or by repeated DNA sequencing of independent PCR products...
  22. ncbi ALOX5 variants associated with susceptibility to human pulmonary tuberculosis
    Florian Herb
    Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
    Hum Mol Genet 17:1052-60. 2008
    ..003, OR 1.50). Our observation of an association of ALOX5 variants with susceptibility to TB contributes evidence of the importance of 5-LO products to the regulation of immune responses to M. tuberculosis...
  23. ncbi Association of Plasmodium falciparum chloroquine resistance transporter variant T76 with age-related plasma chloroquine levels
    Jurgen May
    Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine Hamburg, Germany
    Am J Trop Med Hyg 68:143-6. 2003
    ..5% in children > or = 6 years old (P < 0.01). The association of actual blood levels of CQ and the occurrence of pfcrt T76 underlines that the pfcrt T76 variant is in fact the mediator of CQ resistance...
  24. ncbi Malaria, mummies, mutations: Tutankhamun's archaeological autopsy
    Christian Timmann
    Department of Molecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Bernhard Nocht Strasse 74, Hamburg, Germany
    Trop Med Int Health 15:1278-80. 2010
    ..We are sceptical towards this elucidation of the cause of death of King Tut and discuss alternative and differential diagnoses, among them, in particular, sickle cell disease and Gauche’s disease...
  25. ncbi Chloroquine-resistant malaria in Malawi
    Robin Kobbe
    N Engl J Med 356:868; author reply 869. 2007
  26. ncbi Low frequency of deafness-associated GJB2 variants in Kenya and Sudan and novel GJB2 variants
    Nagla M A Gasmelseed
    Institute of Nuclear Medicine, Molecular Biology and Oncology, University of Gezira, Wad Medani, Sudan
    Hum Mutat 23:206-7. 2004
    ..Compared to many other ethnic groups, deafness-associated variants of the coding region of GJB2 are rare in Sudan and Kenya, suggesting a role of other genetic, or epigenetic factors as a cause for deafness in these countries...
  27. ncbi Editorial: antifolates in prevention of HIV-associated opportunistic infections and in intermittent preventive treatment of malaria in Africa
    Robin Kobbe
    Trop Med Int Health 10:293-4. 2005
  28. ncbi Mycobacterium tuberculosis drug resistance, Ghana
    Ellis Owusu-Dabo
    Emerg Infect Dis 12:1171-2. 2006
  29. ncbi Selection for deafness?
    Christian G Meyer
    Nat Med 8:1332-3. 2002
  30. ncbi Editorial: Gin tonic revisited
    Christian G Meyer
    Trop Med Int Health 9:1239-40. 2004